What is Eikon Therapeutics, Inc. 's total assets?

Eikon Therapeutics, Inc. (EIKN) reported total assets of $850.83M in Q1 2026.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

MYR GroupMYRG

$1.67B+9.9%

BeldenBDC

$3.46B+5.8%

Cabot CorporationCBT

$3.9B+3.0%

UnifirstUNF

$2.8B+2.5%

HES

Hess MidstreamHESM

$4.32B+1.3%

Main Street CapitalMAIN

$5.83B+10.5%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's total assets?: Eikon Therapeutics, Inc. (EIKN) reported total assets of $850.83M in Q1 2026.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.